Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-13
Interim MD&A - English.pdf
Results 2026-05-13
Interim financial statements/report – English.pdf
Results 2026-05-13
Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update
News release - English.pdf
News 2026-04-15
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B
News release - English.pdf
Results 2026-03-23 Financials
Annual MD&A - English.pdf
Results 2026-03-23 Financials
Audited annual financial statements – English.pdf
Results 2026-03-23 Financials
Annual report on form 10-K - English.pdf
News 2026-03-23
Other.pdf
Results 2026-03-23
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
News release - English.pdf
News 2026-03-03
Other.pdf
Transactions 2026-03-03 M&A
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
News release - English.pdf
News 2026-02-20
Other.pdf
News 2026-02-06
Other.pdf
News 2026-01-16
Other.pdf
News 2025-12-11
Other.pdf
Results 2025-11-13 Financials
Interim MD&A - English.pdf
Results 2025-11-13 Financials
Interim financial statements/report – English.pdf
News 2025-11-13
News release - English.pdf
News 2025-11-13
Other.pdf
News 2025-10-07
Other.pdf
News 2025-10-07
News release - English.pdf
News 2025-09-10
Other.pdf
Results 2025-08-06 Financials
Interim MD&A - English.pdf
Results 2025-08-06 Financials
Interim financial statements/report – English.pdf
News 2025-08-06
News release - English.pdf
News 2025-08-06
Other.pdf
News 2025-06-25
News release - English.pdf
News 2025-06-25
Other.pdf